Articles tagged "Weight"

2021 American Transplant Congress
Frailty Component Trajectories Among Kidney Transplant Recipients
N. Chu, X. Chen, D. Segev, M. McAdams-DeMarco
Johns Hopkins, Baltimore, MD
*Purpose: Frailty is associated with decreased access to kidney transplantation (KT) and poor post-KT outcomes. Little is known about how an acute stressor, like KT,…
2021 American Transplant Congress
The Differential Impact of Size Mismatch in Live versus Deceased Donor Kidney Transplant
A. J. Vinson¹, T. Skinner², B. Kiberd³, D. Clark¹, K. Tennankore¹
¹Division of Nephrology, Department of Medicine, Nova Scotia Health Authority, Halifax, NS, Canada, ²Department of Urology, Nova Scotia Health Authority, Halifax, NS, Canada, ³Dalhousie University, Halifax, NS, Canada
*Purpose: The risk of significant weight mismatch between donors and recipients (D-R) undergoing living donor kidney transplant (LDKT) is not well established. Further, how this…
2021 American Transplant Congress
Development Following Pediatric Kidney Transplantation
L. Pape, J. Prüfe
Pediatrics II, University Hospital of Essen, Essen, Germany
*Purpose: Kidney transplantation for children suffering CKD5 has been established in Germany approximately 50 years ago. While in the early decades the focus was merely…
2020 American Transplant Congress
Liver Transplantation in Obese Recipients: Post-Transplant Weight Gain and Outcomes
D. Soma¹, Y. Park¹, P. Mihaylov¹, B. Ekser¹, M. S. Ghabril², M. A. Lacerda², N. Chalasani², R. S. Mangus¹, C. A. Kubal¹
¹Transplant Division, Department of Surgery, Indiana University School of Medicine, Indianapolis, IN, ²Transplant Hepatology, Division of Gastroenterology, Indiana University School of Medicine, Indianapolis, IN
*Purpose: Non-alcoholic fatty liver disease is now the most common cause of end-stage liver disease necessitating orthotopic liver transplantation (OLT) in the United States. Several…
2020 American Transplant Congress
The Influence of Donor Kidney to Recipient Body Weight Ratio on Long-Term Outcomes of Living-Donor Kidney Transplantation
N. Sato, Y. Kakuta, T. Kanzawa, K. Unagami, M. Okumi, H. Ishida, K. Tanabe
Urology, Tokyo Women's Medical University, Shinjuku-ku, Tokyo, Japan
*Purpose: We often experience the incompatibility in size between the kidney graft and recipient in living-donor kidney transplantation. This study evaluated the effect of the…
2020 American Transplant Congress
Should Steatotic Livers Be Transplanted Into Pediatric Recipients?
M. MacConmara, C. Feizpour, P. Vagefi, C. Ramirez, L. DeGregorio, C. S. Hwang
UT Southwestern, Dallas, TX
*Purpose: Although steatotic livers are frequently transplanted in the adult population, they are not commonly transplanted in pediatric recipients. We questioned if the outcomes of…
2020 American Transplant Congress
Outcomes Associated with Mycophenolate Weight-Based Dosing in Varying Immunologic Risk Kidney Transplant Recipients
A. A. Al-Bahou, A. R. Webb, M. Bloxam, L. J. Bowman Anger, R. S. Baliga, A. J. Brueckner
Tampa General Hospital, Tampa, FL
*Purpose: Mycophenolate acid (MPA) is traditionally dosed in kidney transplant recipients (KTR) using the FDA-approved fixed dosing which is irrespective of patient-specific variables such as…
2020 American Transplant Congress
The Influence of the Donor Kidney Weight to Recipient Body Weight Ratio on Long-Term Renal Graft Outcomes
S. Yang¹, J. Lee¹, Y. Jung², B. Kim³, M. Kim¹, S. Kim¹, Y. Kim¹, K. Huh¹
¹Department of Transplantation Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of, ²Department of Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of, ³Department of Nephrology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of
*Purpose: To study the impact of the relative donor kidney size on long-term graft function and survival, we investigated the living donor renal transplants outcomes.*Methods:…
2020 American Transplant Congress
Safety Outcomes in Lower-Weight vs Higher-Weight Recipients of Fixed Dose Alemtuzumab for Kidney Transplant Induction
A. Freeman, S. Anders, B. Wise, M. Janusek, L. Hutchinson, U. Kaszubski, D. Marroquin, D. Martin, H. Bohorquez
Ochsner Medical Center, New Orleans, LA
*Purpose: Alemtuzumab is a lymphocyte-depleting monoclonal antibody used for renal transplant induction, and is associated with significant leukopenia, increased infections and malignancy. Multiple dosing strategies…
2020 American Transplant Congress
Non-Linear Relationship between Recipient BMI and Survival Outcomes after Liver Transplantation-A Dose-Response Meta-Analysis
T. Song
Organ Transplantation Center, Urology Department, Urology Research Institute, West China Hospital, Sichuan University, Chengdu City, China
*Purpose: Dose-response relationship between preoperative and postoperative body mass index (BMI) and survival outcomes after liver transplantation (LT) has not been clearly defined yet.*Methods: PubMed,…